AtaiBeckley (ATAI) Current Taxes (2020 - 2026)

AtaiBeckley (ATAI) posted quarterly Current Taxes of $75000.0 for Q1 2026, up 275.0% quarter-over-quarter from $20000.0 in Q4 2025.

Analysis

AtaiBeckley (ATAI) Current Taxes (2020 - 2026) Analysis & Trends

AtaiBeckley's Current Taxes history runs 3 years deep, the most recent figure standing at $75000.0 for Q1 2026.

In Q1 2026, Current Taxes changed N/A year-over-year to $75000.0; the TTM figure through Mar 2026 stood at $75000.0 (changed N/A YoY), while the FY2025 annual figure was $20000.0, down 89.36% from the prior year.
Current Taxes for Q1 2026 stood at $75000.0, up from $20000.0 in the prior quarter.
Over five years, Current Taxes peaked at $8.1 million in Q4 2021 and troughed at $43000.0 in Q3 2025.
A 5-year average of $2.6 million and a median of $808000.0 in 2023 frame the typical range for Current Taxes.
Peak annual rise in Current Taxes reached 89.36% in 2025, while the deepest fall reached 89.36% in 2025.
AtaiBeckley's Current Taxes stood at $188000.0 in 2024, then slumped by 89.36% to $20000.0 in 2025, then surged by 275.0% to $75000.0 in 2026.
Business Quant data shows ATAI's Current Taxes at $75000.0 in Q1 2026, $20000.0 in Q4 2025, and $188000.0 in Q4 2024.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Taxes (Qtr)
1	Vertex Pharmaceuticals	138.47 Bn	130.62 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.18 Bn	77.19 Bn	3.93 Bn	-
3	Argenx Se	63.38 Bn	58.19 Bn	1.37 Bn	49.00 Mn
4	Moderna	58.09 Bn	52.95 Bn	52.00 Mn	-
5	Revolution Medicines	44.33 Bn	44.33 Bn	-	-
6	BeOne Medicines	40.02 Bn	34.92 Bn	1.53 Bn	76.32 Mn
7	Alnylam Pharmaceuticals	35.57 Bn	32.27 Bn	992.69 Mn	-
8	Royalty Pharma	28.45 Bn	27.61 Bn	-	-
9	Insmed	27.48 Bn	26.32 Bn	358.27 Mn	-
10	AtaiBeckley	1.61 Bn	1.61 Bn	-	43,000.00

Historic Data

Download Data